Trials / Conditions / Respiratory Syncytial Virus Hospitalizations

Respiratory Syncytial Virus Hospitalizations

3 registered clinical trials studyying Respiratory Syncytial Virus Hospitalizations.

Status	Trial	Sponsor	Phase
Completed	The Impact of the 2025 Infant and Maternal Respiratory Syncytial Virus (RSV) Prevention Program on RSV-related NCT07164430	Nicola Irwin	—
Completed	First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in th NCT07177508	Nicola Irwin	—
Completed	An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants NCT02273882	AstraZeneca	—